In today’s world, chronic conditions like obesity, diabetes, and their related health risks affect millions globally. According to the World Health Organization, Roughly 422 million individuals globally are diagnosed with diabetes, and around 1.5 million fatalities can be directly linked to diabetes.
Advancing age also leads to concerns about sagging skin, wrinkles, and an imbalanced physique. Cosmetic procedures can refresh your appearance, but getting to the root of the problem requires internal healing.
This is where peptide therapies like incretin semaglutide are creating ripples in the world of medicine. As experts in non-surgical aesthetic treatments, the team at Dr. V Medical Aesthetics understands the transformative power of incretin mimetics.
Read on as we explore common questions about semaglutide and how it promotes wellness:
Let Dr. V and our staff help you discover the true beauty hiding within. Book your consultation with us today to learn more about your ideal cosmetic treatment.
Incretins are gut hormones released after eating that regulate blood sugar levels post-meals. The two main incretin hormones are GLP-1 and GIP. They stimulate insulin secretion from pancreatic beta cells while inhibiting glucagon release. This results in reduced blood glucose levels after eating.
As an incretin mimetic, semaglutide copies the effects of naturally occurring GLP-1. It activates GLP-1 receptors in the body, promoting insulin release in response to food intake. At the same time, it suppresses glucagon secretion. Together, these effects enable better glycemic control.
Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity treatment. It mirrors native GLP-1 action to control blood sugar.
Specifically, semaglutide:
1 | Activates GLP-1 receptors to heighten glucose-dependent insulin secretion and decelerate gastric emptying |
2 | Is approved for weekly subcutaneous injection to improve glycemic control in adults with type 2 diabetes |
3 | Also approved for chronic weight management in overweight/obese adults alongside reduced calorie intake and more activity |
4 | Belongs to the GLP-1 receptor agonist class that elevates GLP-1 and GIP levels through incretin effect |
Struggling With Diabetes and Obesity? Semaglutide Could Be Your Breakthrough - Ask Dr. V Medical Aesthetics
Semaglutide offers several therapeutic benefits by acting as an incretin mimetic. As an analog of the incretin hormone GLP-1, semaglutide mimics the effects of endogenous GLP-1 on multiple physiological processes:
Semaglutide as an incretin mimetic stimulates the release of insulin and suppresses the release of glucagon from the pancreas. This results in better control of blood glucose levels.
Specifically, semaglutide has several medicinal uses:
By stimulating insulin release and suppressing glucagon, semaglutide helps lower blood sugar levels in patients with type 2 diabetes. It is typically prescribed along with diet and exercise modifications for glycemic control in adults with type 2 diabetes. Clinical trials have shown it is effective at lowering HbA1c levels compared to placebo.
Semaglutide is also approved for chronic weight management in obese or overweight adults. By delaying gastric emptying, increasing satiety and decreasing food intake, semaglutide promotes weight loss. In clinical trials, patients taking semaglutide had significantly greater reductions in body weight compared to placebo. In 2021, the FDA approved a high dose semaglutide injection specifically for weight management.
Recent research indicates semaglutide may also have benefits in patients with NAFLD by improving liver enzymes and reducing liver fat content. However, more studies are needed to confirm its efficacy.
Drug name | Indication | Starting dose | Maximum dose | Notes |
Ozempic (semaglutide) | Type 2 diabetes | 0.25mg weekly | 2mg weekly | Higher 2.4mg weekly doses offer added glycemic and weight loss benefits versus other incretins but also increase gastrointestinal side effects. Temporarily adjusting/holding doses may be needed for procedures as per guidelines. |
Wegovy (semaglutide) | Obesity | 0.25mg weekly | 2.4mg weekly | Higher 2.4mg weekly doses offer added glycemic and weight loss benefits versus other incretins but also increase gastrointestinal side effects. Temporarily adjusting/holding doses may be needed for procedures as per guidelines. |
Rybelsus (oral semaglutide) | Type 2 diabetes | 3mg daily | 7mg daily after 30 days | Higher 2.4mg weekly doses offer added glycemic and weight loss benefits versus other incretins but also increase gastrointestinal side effects. Temporarily adjusting/holding doses may be needed for procedures as per guidelines. |
As with any medication, semaglutide can cause side effects like:
In summary, semaglutide is an innovative incretin mimetic offering effective type 2 diabetes and obesity management, with weight loss as a major benefit. It activates GLP-1 receptors, mirroring the effects of endogenous GLP-1.
Though injection is the standard route, an oral formulation is also available. Semaglutide enhances glycemic control through increased insulin and reduced glucagon levels. It also promotes satiety, enabling weight reduction when combined with lifestyle changes.
At Dr. V Medical Aesthetics, our team specializes in cutting-edge anti-aging treatments and medical aesthetics procedures for overall wellbeing. Alongside semaglutide therapy for chronic disease management, we provide:
With individualized care, advanced techniques, and a holistic outlook, we can help you look and feel your best. Contact us today to discover how semaglutide can enhance your health journey when combined with our non-invasive services.
Let us craft a bespoke wellness plan tailored to your needs and goals. Call us at 850-407-2803 for more details.
Dr. V Medical Aesthetics is ready to help you achieve your beauty goals. Contact us today to learn more about any of our services, and exactly what our team can do for you.